Pillar Biosciences

Pillar Biosciences is a private biotechnology company providing targeted NGS kitted panels and companion diagnostics for oncology. Its core innovation is the SLIMamp® technology, which simplifies library preparation into a single-tube, automatable workflow, addressing key challenges of cost, turnaround time, and sample quality in clinical NGS. The company offers a portfolio of over 20 RUO and IVD products, primarily under the oncoReveal® brand, targeting solid tumors, hematologic cancers, and liquid biopsy, and serves both clinical laboratories and biopharma partners. Pillar's mission is to accelerate the adoption of precision medicine by making actionable genomic testing more accessible globally.

Proprietary SLIMamp® technology for single-tube, multiplex PCR-based NGS library preparation, integrated with PiVAT® bioinformatics and VersaTile™ assay design platforms.

Pillar competes in the targeted NGS panel market against giants like Illumina and Thermo Fisher Scientific, who offer integrated instrument/assay ecosystems, as well as against other specialized diagnostic companies. Its differentiation lies in the simplicity and efficiency of its single-tube SLIMamp® workflow for challenging samples.